Document is current
Any future updates will be listed below
-
Authors
Țica, Otilia
Țica, Ovidiu
Bunting, Karina V.
deBono, Joseph
Gkoutos, Georgios V.
Popescu, Mircea I.
Kotecha, Dipak http://orcid.org/0000-0002-2570-9812
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (BigData@Heart 116074)
- License Information
-
More Information
Article History
Received: 22 April 2022
Accepted: 17 August 2022
First Online: 5 October 2022
Declarations
:
: The study was conducted in accordance with the ethical principles set out in the Helsinki Declaration and Recommendations for Good Clinical Practice and was approved by the SCJUO Ethics Committee (32926/2017) without the need for individual patient consent.
: The images used are entirely unidentifiable, and there are no details on individuals reported within the manuscript.
: All authors have completed the ICMJE uniform disclosure form and declare the following: Otilia Tica received salary funding from the EU/EEPIA Innovative Medicines Initiative (BigData@Heart 116074) and Amomed Pharma, awarded to Professor Kotecha. Professor Kotecha reports grants from the National Institute for Health Research (NIHR CDF-2015–08-074 RATE-AF; NIHR HTA-130280 DaRe2THINK), the British Heart Foundation (PG/17/55/33087 and AA/18/2/34218), EU/EFPIA Innovative Medicines Initiative (BigData@Heart 116074), the European Society of Cardiology supported by educational grants from Boehringer Ingelheim/BMS-Pfizer Alliance/Bayer/Daiichi Sankyo/Boston Scientific, the NIHR/University of Oxford Biomedical Research Centre and British Heart Foundation/University of Birmingham Accelerator Award (STEEER-AF NCT04396418) and Amomed Pharma and IRCCS San Raffaele/Menarini (Beta-blockers in Heart Failure Collaborative Group NCT0083244), in addition to personal fees from Bayer (Advisory Board), AtriCure (Speaker fees), Amomed (Advisory Board), Protherics Medicines Development (Advisory Board) and Myokardia (Advisory Board). Dr. Ovidiu Tica, Dr. deBono, Professor Popescu and Professor Gkoutos declare that they have no competing interests. Dr. Bunting was the research fellow for the RATE-AF trial funded by the NIHR (NIHR CDF-2015–08-074) and has been awarded a grant from the University of Birmingham’s British Heart Foundation Accelerator Award (BHF AA/18/2/34218) and the British Heart Foundation Fellowship scheme (FS/CDRF/21/21032).
